Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas
- 1 August 1985
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 15 (2) , 181-182
- https://doi.org/10.1007/bf00257535
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Differing Response Rates and Survival Between Squamous and Non-Squamous Non-Small Cell Lung Cancer Comparison of CAP Versus MAPAmerican Journal of Clinical Oncology, 1986
- Failure of bleomycin to improve the therapeutic effects of a combination of cyclophosphamide, doxorubicin, and cisplatin (CAP) in advanced sarcomasMedical and Pediatric Oncology, 1984
- Cyclophosphamide, Doxorubicin, and Cisplatin Combined in the Treatment of Advanced SarcomasMedical and Pediatric Oncology, 1983
- A preliminary study of cyclophosphamide (NSC-26271), adriamycin (NSC-123127), imidazole carboxamide (NSC-45388), and actinomycin D (NSC-3053) with or without MER-BCG in patients with advanced sarcomasMedical and Pediatric Oncology, 1978
- The Results of Surgical Treatment Combined with Intra-arterial Infusion of Anti-cancer Agents in OsteosarcomaClinical Orthopaedics and Related Research, 1976
- COMPARATIVE CLINICAL-TRIAL EVALUATING COMBINATION OF ADRIAMYCIN, DTIC, AND VINCRISTINE, COMBINATION OF ACTINOMYCIN-D, CYCLOPHOSPHAMIDE, AND VINCRISTINE, AND A SINGLE AGENT, METHYL-CCNU, IN ADVANCED SARCOMAS1976
- MITOMYCIN-C1961